BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 21855700)

  • 1. Impact of obesity on cardiovascular disease.
    Zalesin KC; Franklin BA; Miller WM; Peterson ED; McCullough PA
    Med Clin North Am; 2011 Sep; 95(5):919-37. PubMed ID: 21855700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic syndrome--from insulin resistance to obesity and diabetes.
    Gallagher EJ; Leroith D; Karnieli E
    Med Clin North Am; 2011 Sep; 95(5):855-73. PubMed ID: 21855696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of obesity on cardiovascular disease.
    Zalesin KC; Franklin BA; Miller WM; Peterson ED; McCullough PA
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):663-84, ix. PubMed ID: 18775358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child.
    l'Allemand-Jander D
    Int J Obes (Lond); 2010 Dec; 34 Suppl 2():S32-6. PubMed ID: 21151144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic complications of obesity in childhood and adolescence: more than just diabetes.
    Nathan BM; Moran A
    Curr Opin Endocrinol Diabetes Obes; 2008 Feb; 15(1):21-9. PubMed ID: 18185059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease.
    Rana JS; Nieuwdorp M; Jukema JW; Kastelein JJ
    Diabetes Obes Metab; 2007 May; 9(3):218-32. PubMed ID: 17391148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and dyslipidemia.
    Franssen R; Monajemi H; Stroes ES; Kastelein JJ
    Med Clin North Am; 2011 Sep; 95(5):893-902. PubMed ID: 21855698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of obesity on health outcomes.
    Dixon JB
    Mol Cell Endocrinol; 2010 Mar; 316(2):104-8. PubMed ID: 19628019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Obesity and cardiovascular diseases-theoretical background and therapeutic consequences].
    Völler H; Schmailzl KJ; Bjarnason-Wehrens B
    Z Kardiol; 2004 Jul; 93(7):503-13. PubMed ID: 15243761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and metabolic disease.
    Koopman RJ; Swofford SJ; Beard MN; Meadows SE
    Prim Care; 2009 Jun; 36(2):257-70. PubMed ID: 19501242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.
    Misra A; Khurana L
    Metab Syndr Relat Disord; 2009 Dec; 7(6):497-514. PubMed ID: 19900153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
    Haffner SM
    Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():121S-127S. PubMed ID: 16931493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional performance of the cardiovascular system in patients with overweight and obesity].
    Bogdanov AR; Derbeneva SA; Strokova TV; Surkov AG; Kaganov BS
    Vopr Pitan; 2012; 81(1):69-74. PubMed ID: 22642168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism, lifestyle and bipolar affective disorder.
    Morriss R; Mohammed FA
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):94-101. PubMed ID: 16280342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome and its cardiovascular manifestations.
    Sánchez-Torres RJ; Delgado-Osorio H
    Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.